SECURITIES AND EXCHANGE LETTER
Published on January 11, 1999
EXHIBIT 99
Access Pharmaceuticals, Inc.
2600 Stemmons Freeway, Suite 176
Dallas, TX 75207-2107
Janaury 11, 1999
Paul Fischer, Esq.
Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
Re: Registration Statement on Form SB-2; File No. 333-62463
Dear Mr. Fischer:
The undersigned registrant hereby requests that the Securities and
Exchange Commission take appropriate action to cause the effective date
of the above referenced Registration Statement on Form SB-2 to be
accelerated such that the Registration Statement will become effective
at 2:00 p.m. EST on Janaury 11, 1999 or as soon as practicable
thereafter.
Very truly yours
/s/ Kerry P. Gray
-----------------
Kerry P. Gray
President & CEO
Access Pharmaceuticals, Inc.